Impact of Tumor Size on Probability of Pathologic Complete Response After Neoadjuvant Chemotherapy

BACKGROUND: The prospective Neoadjuvant Breast Symphony Trial (NBRST) study found that MammaPrint/BluePrint functional molecular subtype is superior to conventional immunohistochemistry/fluorescence in situ hybridization subtyping for predicting pathologic complete response (pCR) to neoadjuvant chem...

Descripción completa

Detalles Bibliográficos
Autores principales: Baron, Paul, Beitsch, Peter, Boselli, Danielle, Symanowski, James, Pellicane, James V., Beatty, Jennifer, Richards, Paul, Mislowsky, Angela, Nash, Charles, Lee, Laura A., Murray, Mary, de Snoo, Femke A., Stork-Sloots, Lisette, Gittleman, Mark, Akbari, Stephanie, Whitworth, Pat
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2015
Materias:
Breast Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4819747/
https://www.ncbi.nlm.nih.gov/pubmed/26714960
http://dx.doi.org/10.1245/s10434-015-5030-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4819747/
https://www.ncbi.nlm.nih.gov/pubmed/26714960
http://dx.doi.org/10.1245/s10434-015-5030-1

Ejemplares similares